Back To Our Contents Page || Back To Our Coprorate Listings

---

Senior Management J. Joseph Marr, M.D. President and Chief Operating Officer J. Richard Crowley Chief Financial Officer and Treasurer	Board of Directors C. Garrison Fathman, M.D. Professor, Department of Medicine, Stanford University School of Medicine Samuel C. Fleming Chairman and Chief Executive Officer, Decision Resources, Inc. Paul Friedman, M.D. President Dupont Merck Research Labs Carl S. Goldfischer, M.D. Chief Financial Officer, Vice President Finance and Strategic Planning, ImClone Systems, Inc.	Geraldine A. Henwood Chief Executive Officer, IBAH, Inc. J. Joseph Marr, M.D. President and Chief Operating Officer, ImmuLogic Pharmaceutical Corporation Richard F. Pops Chief Executive Officer, Alkermes, Inc.

Corporate Headquarters ImmuLogic Pharmaceutical Corporation 610 Lincoln Street Waltham, Massachusetts 02154 Tel: 781-466-6000 Fax: 781-466-6010 Auditors Coopers & Lybrand L.L.P. One International Place Boston, Massachusetts 02110

Legal Counsel Hale and Dorr LLP 60 State Street Boston, Massachusetts 02109 Transfer Agent and Registrar Bank of Boston c/o Boston Equiserve P.O. Box 8040 Boston, Massachusetts 02266-8040 Tel: 781-575-3400 Web: www.Equiserve.com

Securities and Related Information The Company's Common Stock is traded on the Nasdaq National Market under the symbol IMUL. As of December 31, 1997, there were approximately 304 holders of record of the Company's Common Stock. The Company has not paid dividends on its Common Stock since inception. Stockholder Inquiries Communications concerning stock transfer requirements, lost certificates, and changes of address should be directed to the transfer agent. Other stockholder or investor inquiries should be directed to Investor Relations at the Company's address or phone number above. Annual Meeting The Annual Meeting of Stockholders will be held on June 17, 1998, at 9:00 am at the Company's headquarters, 610 Lincoln Street, Waltham, Massachusetts.

TOP